Clinical Trials Browser

Phase 2 × Lung Neoplasms × Vaccines × Clear all

NCT00654030 2018-04-09

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

Phase 2 Completed

12 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms